Biggest News Aggregation in the World
📰 Forward Pharma News

Page 4 - Forward Pharma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Forward Pharma. Real-time updates on events, politics, business and more.

Forward Pharma A/S (NASDAQ:FWP) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Forward Pharma A/S (NASDAQ:FWP – Get Rating) in a report released on Friday. The firm set a “sell” rating on the biotechnology company’s stock. Forward Pharma A/S stock opened at $5.40 on Friday. Forward Pharma A/S has a 1-year low of $5.05 and a 1-year high of $20.31. The […]
Morgan Stanley Goldman Sachs Group Inc Citadel Advisors Renaissance Technologies Forward Pharma Get Rating

Forward Pharma A/S (NASDAQ:FWP) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Forward Pharma A/S (NASDAQ:FWP – Get Rating) in a report published on Wednesday morning. The firm issued a sell rating on the biotechnology company’s stock. Shares of FWP opened at $5.38 on Wednesday. Forward Pharma A/S has a 12 month low of $5.05 and a 12 month high of […]
Morgan Stanley Goldman Sachs Group Inc Citadel Advisors Renaissance Technologies Forward Pharma Get Rating

Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020

Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020 Forward Pharma A/S Hawthorne, New York, UNITED STATES COPENHAGEN, Denmark, April 14, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated financial results for the year ended December 31, 2020. Our net loss for the year ended December 31, 2020 wa...
United States John Graziano Claus Bo Svendsen Exchange Commission Opposition Division Of The European Patent Office Opposition Division

Chutes & Ladders—After Verastem pit stop, bluebird vet Neumann lands at Kite

Editas Medicine  James Mullen takes over as CEO from Feb. 15. Editas chairman Mullen will don the CEO mantle Feb. 15, taking over for current Editas chief Cynthia Collins. Before jumping to the Editas team, Mullen was CEO and director of the CDMO Patheon—later snapped up by Thermo Fisher—and also served as the CEO of Biogen. In a brief release, Editas didn’t say why Collins was leaving. “It has been a privilege to lead Editas Medicine and this extremely talented team,” she said in ...
New York United States British Columbia United Kingdom Bryan Lake San Francisco

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Dewpoint Therapeutics Appoints Joel Sendek as Chief Financial Officer

Dewpoint Therapeutics Appoints Joel Sendek as Chief Financial Officer - Sendek adds 30 years experience in biotechnology leadership News provided by Share this article Share this article BOSTON, Feb. 11, 2021 /PRNewswire/ -- Dewpoint Therapeutics, the biomolecular condensates company, today announced it has appointed Joel Sendek as Chief Financial Officer and Treasurer. "As we accelerate our growth plans, Joels financial expertise and leadership in fundraising and corporate finance for both p...
United States Stifel Financial Corp Goldman Sachs Rice University Progenics Pharmaceuticals Dewpoint Therapeutics

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science